Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2010 1
2012 1
2013 2
2014 2
2015 1
2018 2
2019 2
2020 1
2021 5
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes.
Yesildag B, Mir-Coll J, Neelakandhan A, Gibson CB, Perdue NR, Rufer C, Karsai M, Biernath A, Forschler F, Jin PW, Misun PM, Title A, Hierlemann A, Kreiner FF, Wesley JD, von Herrath MG. Yesildag B, et al. Among authors: wesley jd. Clin Immunol. 2022 Nov;244:109118. doi: 10.1016/j.clim.2022.109118. Epub 2022 Sep 6. Clin Immunol. 2022. PMID: 36084852
Non-antigenic and antigenic interventions in type 1 diabetes.
Rydén AK, Wesley JD, Coppieters KT, Von Herrath MG. Rydén AK, et al. Among authors: wesley jd. Hum Vaccin Immunother. 2014;10(4):838-46. doi: 10.4161/hv.26890. Epub 2013 Oct 28. Hum Vaccin Immunother. 2014. PMID: 24165565 Free PMC article. Review.
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.
Reznichenko A, Nair V, Eddy S, Fermin D, Tomilo M, Slidel T, Ju W, Henry I, Badal SS, Wesley JD, Liles JT, Moosmang S, Williams JM, Quinn CM, Bitzer M, Hodgin JB, Barisoni L, Karihaloo A, Breyer MD, Duffin KL, Patel UD, Magnone MC, Bhat R, Kretzler M. Reznichenko A, et al. Among authors: wesley jd. Kidney Int. 2024 Jan 27:S0085-2538(24)00068-1. doi: 10.1016/j.kint.2024.01.012. Online ahead of print. Kidney Int. 2024. PMID: 38286178 Free article.
Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
Pagni PP, Chaplin J, Wijaranakula M, Wesley JD, Granger J, Cracraft J, O'Brien C, Perdue N, Kumar V, Li S, Ratliff SS, Roach A, Misquith A, Chan CL, Coppieters K, von Herrath M. Pagni PP, et al. Among authors: wesley jd. Diabetes. 2021 Aug 13;71(1):157-69. doi: 10.2337/db21-0327. Online ahead of print. Diabetes. 2021. PMID: 34389610 Free PMC article.
Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
Pagni PP, Chaplin J, Wijaranakula M, Wesley JD, Granger J, Cracraft J, O'Brien C, Perdue N, Kumar V, Li S, Ratliff SS, Roach A, Misquith A, Chan CL, Coppieters K, von Herrath M. Pagni PP, et al. Among authors: wesley jd. Diabetes. 2021 Aug 13:db210327. doi: 10.2337/db21-0327. Online ahead of print. Diabetes. 2021. PMID: 34957480
20 results